Mebendazole-amine

Cat. No.: HY-114750 Purity: 98.35%: FAQs
Data Sheet SDS COA Handling Instructions

Molarity Calculator

Mebendazole-amine is a metabolite of Mebendazole. Mebendazole is a broad-spectrum benzimidazole anti-helminthic agent.

For research use only. We do not sell to patients.

Mebendazole-amine Chemical Structure

CAS No. : 52329-60-9

Size	Price	Stock	Quantity
1 mg	USD 76	In-stock	Estimated Time of Arrival: December 31
5 mg	USD 168	In-stock	Estimated Time of Arrival: December 31
10 mg	USD 270	In-stock	Estimated Time of Arrival: December 31
25 mg		Get quote	Estimated Time of Arrival: December 31

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Other Forms of Mebendazole-amine:

Mebendazole-amine-¹³C₆ Get quote
Mebendazole-amine (Standard) Get quote

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description

Mebendazole-amine is a metabolite of Mebendazole. Mebendazole is a broad-spectrum benzimidazole anti-helminthic agent^[1].

Cellular Effect

Cell Line	Type	Value	Description	References
HL-60	EC₅₀	> 30 μM Compound: 3	Cytotoxicity against human HL60 cells after 48 to 72 hrs by Alamar blue assay Cytotoxicity against human HL60 cells after 48 to 72 hrs by Alamar blue assay	[PMID: 22795629]

Molecular Weight

237.26

Formula

C₁₄H₁₁N₃O

CAS No.

52329-60-9

Appearance

Solid

Color

White to off-white

SMILES

O=C(C1=CC=C2N=C(N)NC2=C1)C3=CC=CC=C3

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

Purity & Documentation

Purity: 98.35%

Select Batch:

Data Sheet (265 KB) SDS (392 KB)

COA (246 KB) Elemental Analysis Report (104 KB)

Handling Instructions (2659 KB)

References

[1]. Majewsky M, et al. Systematic identification of suspected anthelmintic benzimidazole metabolites using LC-MS/MS. J Pharm Biomed Anal. 2018;151:151-158. [Content Brief]

[2]. Pantziarka P, et al. Repurposing Drugs in Oncology (ReDO)-mebendazole as an anti-cancer agent. Ecancermedicalscience. 2014;8:443. Published 2014 Jul 10. [Content Brief]